Chemoprotective effects of curcumin on doxorubicin-induced nephrotoxicity in wistar rats: by modulating inflammatory cytokines, apoptosis, oxidative stress and oxidative DNA damage
Özet
Doxorubicin (DXR) is one of the most important chemotherapeutic agent. However, nephrotoxicity reduces its clinical utility in humans. The aim of the study was to investigate protective effects of curcumin (CMN) against DXR-induced nephrotoxicity. Rats were subjected to oral treatment of CMN (100 and 200 mg/kg body weight) for 7 days. Nephrotoxicity was induced by single intra peritoneal injection of DXR (40 mg/kg body weight) on the fifth day and then the experiment was terminated on the eighth day. Nephroprotective effects of CMN were associated with decrease in serum toxicity markers and increase in antioxidant enzyme activities. CMN was able to reduced the levels of inflammatory markers such as TNF-α, NF-κB, IL-1β, iNOS and COX-2 in the rats. It also reduced the expressions of apoptotic marker including caspase-3, and oxidative DNA damage marker including 8-OHdG. Collectively, these findings indicated that CMN protect against DXR-induced nephrotoxicity.
Anahtar Kelimeler
- Scopus
- 116
- WoS
- 111
- OpenAlex
- 122
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Benzer, Fulya | |
| dc.contributor.author | Kandemir, Fatih Mehmet | |
| dc.contributor.author | Kucukler, Sefa | |
| dc.contributor.author | Comaklı, Selim | |
| dc.contributor.author | Caglayan, Cuneyt | |
| dc.date.accessioned | 2026-10-28T14:56:40.418738379Z | |
| dc.date.available | 2026-10-28T14:56:40.418738379Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Doxorubicin (DXR) is one of the most important chemotherapeutic agent. However, nephrotoxicity reduces its clinical utility in humans. The aim of the study was to investigate protective effects of curcumin (CMN) against DXR-induced nephrotoxicity. Rats were subjected to oral treatment of CMN (100 and 200 mg/kg body weight) for 7 days. Nephrotoxicity was induced by single intra peritoneal injection of DXR (40 mg/kg body weight) on the fifth day and then the experiment was terminated on the eighth day. Nephroprotective effects of CMN were associated with decrease in serum toxicity markers and increase in antioxidant enzyme activities. CMN was able to reduced the levels of inflammatory markers such as TNF-α, NF-κB, IL-1β, iNOS and COX-2 in the rats. It also reduced the expressions of apoptotic marker including caspase-3, and oxidative DNA damage marker including 8-OHdG. Collectively, these findings indicated that CMN protect against DXR-induced nephrotoxicity. | |
| dc.description.sponsorship | Munzur University, (YLTUB016–01) | |
| dc.identifier.doi | 10.1080/13813455.2017.1422766 | |
| dc.identifier.eissn | 1744-4160 | |
| dc.identifier.endpage | 457 | |
| dc.identifier.issn | 1381-3455 | |
| dc.identifier.issue | 5 | |
| dc.identifier.pmid | 29302997 | |
| dc.identifier.scopus | 2-s2.0-85040971802 | |
| dc.identifier.startpage | 448 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/munzur/3463 | |
| dc.identifier.volume | 124 | |
| dc.identifier.wos | WOS:000447305900011 | |
| dc.language.iso | en | |
| dc.publisher | Taylor and Francis Ltd | |
| dc.relation.ispartof | Archives of Physiology and Biochemistry | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Apoptosis | |
| dc.subject | curcumin | |
| dc.subject | doxorubicin | |
| dc.subject | inflammation | |
| dc.subject | nephrotoxicity | |
| dc.subject.classification | Biochemistry & Molecular Biology | |
| dc.subject.classification | Biophysics | |
| dc.subject.classification | Endocrinology & Metabolism | |
| dc.subject.classification | Physiology | |
| dc.subject.other | Animals | |
| dc.subject.other | Anti-Inflammatory Agents, Non-Steroidal | |
| dc.subject.other | Antibiotics, Antineoplastic | |
| dc.subject.other | Antioxidants | |
| dc.subject.other | Apoptosis | |
| dc.subject.other | Biomarkers | |
| dc.subject.other | Curcumin | |
| dc.subject.other | Cyclooxygenase 2 | |
| dc.subject.other | DNA Damage | |
| dc.subject.other | Dose-Response Relationship, Drug | |
| dc.subject.other | Doxorubicin | |
| dc.subject.other | Kidney | |
| dc.subject.other | Lipid Peroxidation | |
| dc.subject.other | Male | |
| dc.subject.other | Nitric Oxide Synthase Type II | |
| dc.subject.other | Oxidation-Reduction | |
| dc.subject.other | Oxidative Stress | |
| dc.subject.other | Protective Agents | |
| dc.subject.other | Random Allocation | |
| dc.subject.other | Rats, Wistar | |
| dc.subject.other | Renal Insufficiency | |
| dc.subject.other | Topoisomerase II Inhibitors | |
| dc.subject.other | antineoplastic antibiotic | |
| dc.subject.other | antioxidant | |
| dc.subject.other | biological marker | |
| dc.subject.other | gyrase inhibitor | |
| dc.subject.other | inducible nitric oxide synthase | |
| dc.subject.other | nonsteroid antiinflammatory agent | |
| dc.subject.other | Nos2 protein, rat | |
| dc.subject.other | protective agent | |
| dc.subject.other | Ptgs2 protein, rat | |
| dc.subject.other | animal | |
| dc.subject.other | antagonists and inhibitors | |
| dc.subject.other | blood | |
| dc.subject.other | chemically induced | |
| dc.subject.other | chemistry | |
| dc.subject.other | dose response | |
| dc.subject.other | drug effect | |
| dc.subject.other | immunology | |
| dc.subject.other | kidney failure | |
| dc.subject.other | metabolism | |
| dc.subject.other | oxidation reduction reaction | |
| dc.subject.other | pathology | |
| dc.subject.other | randomization | |
| dc.subject.other | Wistar rat | |
| dc.title | Chemoprotective effects of curcumin on doxorubicin-induced nephrotoxicity in wistar rats: by modulating inflammatory cytokines, apoptosis, oxidative stress and oxidative DNA damage | |
| dc.type | Article | |
| rdl.citation.openalex | 122 | |
| rdl.citation.scopus | 116 | |
| rdl.citation.wos | 111 | |
| rdl.department | a Department of Food Engineering, Faculty of Engineering , Munzur University , Tunceli , Turkey | |
| rdl.department | b Department of Biochemistry, Faculty of Veterinary Medicine , Ataturk University , Erzurum , Turkey | |
| rdl.department | c Department of Pathology, Faculty of Veterinary Medicine , Ataturk University , Erzurum , Turkey | |
| rdl.department | d Department of Biochemistry, Faculty of Veterinary Medicine , Bingol University , Bingol , Turkey | |
| rdl.oa.status | closed | |
| rdl.scopus.quartile | Q2 | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |

